This monkey business [Power / Sample Size]

posted by jag009  – NJ, 2013-06-13 23:42 (4753 d 09:04 ago) – Posting: # 10784
Views: 14,256

❝ ❝ […] Okay, it's from the 2001 guidance and RSABE was introduced much later...


❝ I think that’s the crucial point. At a Pharmaceutical Science Advisory Committee Meeting FDA suggested a minimum of 36 subjects and was voted down (have to dig out the reference). From what I’ve heard at conferences they want 24 – but I was never able to find a reference.


You mean this? Link

Given the fact that the CV>30%, do you think that it's possible for anyone(I mean would anyone dare to)try and pass a RSABE study with n=12? It's risky enough to run a regular submission BE study with n=12 already at CV<30%... I will go check with my professor and see (Dr.Endrenyi) when I go have dinner with him later... :-)

John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
178 visitors (0 registered, 178 guests [including 23 identified bots]).
Forum time: 08:46 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5